The impact of a payer‐provider joint venture on healthcare value
Our findings provide evidence for future payer-provider JVs and demonstrate the importance of having a valid control group when evaluating JVs and value-based payment arrangements.
Authors
- Alison Amidei Galbraith (ORCID: https://orcid.org/0000-0002-7309-5915)
- Fang Zhang (ORCID: https://orcid.org/0000-0002-0300-8273)
- Stephanie Argetsinger
- Matthew Lakoma
- Joseph P. Newhouse (ORCID: https://orcid.org/0000-0001-5837-3203)
- J. Frank Wharam (ORCID: https://orcid.org/0000-0003-2053-0757)
- Laura Faden Garabedian (ORCID: https://orcid.org/0000-0002-0014-4181)
Institutions
- Boston University (US)
- Boston Medical Center (US)
- National Bureau of Economic Research (US)
- Harvard University (US)
- Duke University (US)
- Harvard Pilgrim Health Care (US)
Publication Details
- Journal
- Health Services Research
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1111/1475-6773.14400
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Patrick and Catherine Weldon Donaghue Medical Research Foundation